Offer - Urjas Oil for just ₹ 1 X
Dilnip Trio Tablet is a commercial drug that is prescribed in the form of Tablet. Dilnip Trio Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Dilnip Trio Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Dilnip Trio Tablet are Back Pain, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Dilnip Trio Tablet as well, which are listed below. These side effects of Dilnip Trio Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Dilnip Trio Tablet is Mild for pregnant women and Mild for women who are breastfeeding. It is important to know if Dilnip Trio Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Dilnip Trio Tablet related warnings section.
Dilnip Trio Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia as it can result in adverse effects. Some other conditions that can be affected by Dilnip Trio Tablet are listed in the contraindications section below.
Drug interactions for Dilnip Trio Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Dilnip Trio Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Dilnip Trio Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Dilnip Trio Tablet safe for pregnant women?
Dilnip Trio Tablet has mild to no side effects in pregnant women.
Is the use of Dilnip Trio Tablet safe during breastfeeding?
Dilnip Trio Tablet has been seen to have minimal side effects on breastfeeding women.
What is the effect of Dilnip Trio Tablet on the Kidneys?
Very few cases of side effects of Dilnip Trio Tablet on kidney have been reported.
What is the effect of Dilnip Trio Tablet on the Liver?
Side effects of Dilnip Trio Tablet rarely affect the liver.
What is the effect of Dilnip Trio Tablet on the Heart?
Dilnip Trio Tablet has very mild side effects on the heart.
Dilnip Trio Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Dilnip Trio Tablet unless your doctor advises you to do so -
Is this Dilnip Trio Tablet habit forming or addictive?
No, there is no any evidence that Dilnip Trio Tablet is addictive.
Interaction between Food and Dilnip Trio Tablet
When consumed with certain foods, Dilnip Trio Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Dilnip Trio Tablet
Consuming Dilnip Trio Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448